Study quantifies risks linked to cardiac multimorbidityJuly 7, 2015DiabetesPreventive CareCAD & AtherosclerosisStroke
Angina drug ranolazine lowers glucose in type 2 diabetesJune 24, 2015DiabetesAcute Coronary Syndromes
Lixisenatide news is good, but search for the ‘holy grail’ continuesJune 18, 2015Heart FailureDiabetes
ADA: DPP4 inhibitors and cardiovascular outcomes: connecting the dotsJune 18, 2015CAD & AtherosclerosisHeart FailureDiabetes
ADA: Thiazolidinediones, sulfonylureas best DPP-4s for metformin-based dual GLTJune 15, 2015DiabetesLipid Disorders
AACE: Saroglitazar found safe, effective for management of diabetic dyslipidemiaJune 10, 2015Lipid DisordersDiabetes
ELIXA trial: No cardiovascular risk with GLP-1 receptor agonist lixisenatideJune 9, 2015DiabetesAcute Coronary SyndromesLipid DisordersHeart Failure
Tight glycemic control: Somewhat fewer CV events, same mortalityJune 3, 2015Lipid DisordersDiabetesHeart Failure
OARSI: Chronic conditions complicate osteoarthritis treatment, complianceMay 29, 2015DiabetesLipid DisordersHypertension
